Interstitial Lung Disease

Introduction

If you have been told that you may have, or definitely have, interstitial lung disease — often shortened to ILD — you are likely trying to understand what this diagnosis really means and what comes next. ILD is not a single illness. It is an umbrella name for more than 200 conditions that affect the delicate tissue around the tiny air sacs in your lungs. Some forms move slowly. Others advance more quickly. Many are now treatable in ways that were not possible even ten years ago.

This guide is written for people who have been diagnosed with ILD, are being evaluated for it, or are supporting a family member who is. It explains what ILD is, the main types, how doctors confirm the diagnosis, the treatments available today, and what daily life with ILD can look like. The aim is to help you arrive at conversations with your pulmonologist (a lung specialist) better prepared to ask the right questions about your specific situation.

What Is Interstitial Lung Disease?

Your lungs work by moving oxygen from the air you breathe into your bloodstream. This exchange happens in millions of tiny air sacs called alveoli. Surrounding and supporting these air sacs is a thin layer of tissue called the interstitium. In a healthy lung, this tissue is so thin that oxygen passes through it easily.

In interstitial lung disease, the interstitium becomes inflamed, thickened, or scarred. Scarring of lung tissue is called fibrosis. When the interstitium thickens:

• Oxygen has more difficulty passing into the blood
• The lungs become stiffer and harder to expand
• Breathing feels more effortful, especially during activity

Because so many different diseases can cause this kind of damage, ILD is best thought of as a family of conditions rather than one disease. Some are caused by autoimmune illnesses, some by long-term exposure to dust or fumes, some by medications, and many by causes that remain unknown.

The most important early step is identifying which type of ILD you have. The type guides treatment, monitoring, and what to expect over time.

Types of Interstitial Lung Disease

Idiopathic Pulmonary Fibrosis (IPF)

IPF is one of the most common and most studied forms of ILD. “Idiopathic” means the cause is unknown. It typically affects adults over the age of 60, more often men, and tends to progress over time. Specific antifibrotic medications — described later in this article — were developed largely for IPF.

Other Idiopathic Interstitial Pneumonias

This group includes conditions such as nonspecific interstitial pneumonia (NSIP) and cryptogenic organizing pneumonia (COP). They are also of unknown cause but behave differently from IPF and often respond better to anti-inflammatory treatment.

Connective Tissue Disease-Associated ILD

Autoimmune diseases such as rheumatoid arthritis, scleroderma (systemic sclerosis), Sjögren’s syndrome, lupus, and inflammatory myositis can all cause ILD. In these cases, treating the underlying autoimmune disease is a central part of treating the lung disease.

Hypersensitivity Pneumonitis

This form is caused by an immune reaction to something repeatedly inhaled — bird droppings or feathers, mould in damp homes, certain agricultural dusts, or chemicals in some workplaces. Identifying and removing the trigger is one of the most important steps in care.

Occupational and Environmental ILD

Long-term exposure to dusts such as silica (stone cutting, sandblasting), asbestos, coal dust, or certain metals can cause lung scarring. These conditions are sometimes called pneumoconioses. They are diagnosed partly by a careful work history.

Sarcoidosis

Sarcoidosis is an inflammatory condition that can affect many organs, including the lungs. It can cause small clusters of inflammatory cells called granulomas and, in some people, lead to fibrosis over time.

Drug-Induced ILD

Certain medications can injure lung tissue. These include some chemotherapy drugs, the heart rhythm medication amiodarone, certain antibiotics, and several newer cancer immunotherapy agents. Radiation therapy to the chest can also cause ILD.

Progressive Pulmonary Fibrosis (PPF)

This is a more recent category, recognised by major lung societies including the American Thoracic Society (ATS) and the European Respiratory Society (ERS). It describes any non-IPF ILD that continues to worsen despite treatment of its underlying cause. The PPF label matters because it can open the door to antifibrotic therapy in conditions beyond IPF.

Causes and Risk Factors

Because ILD is a family of conditions, the causes are varied. Known and suspected contributors include:

• Autoimmune diseases — rheumatoid arthritis, scleroderma, lupus, polymyositis, dermatomyositis, Sjögren’s syndrome
• Occupational exposures — silica, asbestos, coal dust, hard metals, certain agricultural and textile dusts
• Environmental triggers — mould, bird antigens, hot tub bacteria, certain organic dusts
• Smoking — linked to specific ILD subtypes and a risk factor for IPF
• Medications — including some chemotherapy agents, amiodarone, nitrofurantoin, methotrexate, and immune checkpoint inhibitors
• Radiation to the chest
• Genetic factors — familial pulmonary fibrosis runs in some families and is linked to specific gene variants
• Gastro-oesophageal reflux — thought to contribute to IPF in some patients
• Unknown causes — idiopathic ILDs by definition

Risk factors that increase the likelihood of developing ILD include older age, male sex (for IPF), a personal or family history of autoimmune disease, long-term smoking, and certain occupational histories. A careful conversation with your doctor about your job, hobbies, home environment, and medications is often as important as imaging tests.

Signs and Symptoms

Most people with ILD describe two main symptoms that creep in slowly:

• Shortness of breath, especially with exertion such as climbing stairs, walking uphill, or carrying loads
• A dry, persistent cough that does not bring up mucus

Other common features include fatigue, unintended weight loss, mild chest discomfort, and in some advanced cases, a widening of the fingertips called clubbing. Some people notice their oxygen level drops during exercise, even if it looks normal at rest.

Because you are reading this as someone who likely already has the diagnosis or is being investigated for it, what is most useful day to day is recognising changes in your usual pattern. Worsening breathlessness over weeks, a new fever, or sudden severe shortness of breath are reasons to contact your specialist promptly. These can signal an acute exacerbation — a rapid worsening that needs urgent assessment.

Diagnosis

Diagnosing ILD usually takes more than one test. Major guidelines from the ATS, ERS, and other lung societies recommend a multidisciplinary approach, where a pulmonologist, a radiologist who specialises in chest imaging, and sometimes a pathologist review the case together.

Medical History and Examination

Your doctor will ask about your symptoms, smoking history, jobs you have held, hobbies (such as bird-keeping), home environment, medications, family history, and any autoimmune symptoms such as joint pain, dry eyes, rashes, or Raynaud’s phenomenon. They will listen to your lungs for a fine crackling sound, sometimes described as Velcro being pulled apart, that is common in pulmonary fibrosis.

High-Resolution CT Scan (HRCT)

HRCT of the chest is the single most important imaging test in ILD. It produces detailed pictures of the lung tissue and shows specific patterns of scarring. Certain patterns, such as usual interstitial pneumonia (UIP), strongly suggest IPF. Other patterns point towards hypersensitivity pneumonitis, NSIP, or sarcoidosis.

Pulmonary Function Tests (PFTs)

• Forced vital capacity (FVC) — the total amount of air you can forcefully breathe out
• Diffusing capacity (DLCO) — how well oxygen passes from your lungs into your bloodstream

Changes in these numbers over time help your doctor judge whether your disease is stable or progressing.

Oxygen Saturation and Walk Tests

A simple finger probe (pulse oximeter) measures oxygen levels. A six-minute walk test looks at how far you can walk in six minutes and whether your oxygen drops with activity. This helps decide whether you need supplemental oxygen.

Blood Tests

Blood tests look for autoimmune antibodies and other markers that point to a specific cause — for example, anti-CCP for rheumatoid arthritis, anti-Scl-70 for scleroderma, or myositis-related antibodies.

Bronchoscopy

In some cases, a thin flexible tube with a camera is passed into the lungs to collect fluid (bronchoalveolar lavage) or small tissue samples. This can help rule out infection or point to specific ILD subtypes such as hypersensitivity pneumonitis or sarcoidosis.

Lung Biopsy

If the diagnosis remains unclear after the steps above, a surgical or transbronchial lung biopsy may be considered. Newer techniques such as transbronchial cryobiopsy, which uses cold to take small tissue samples through a bronchoscope, are increasingly used as a less invasive alternative to surgical biopsy in selected patients.

Treatment and Management

Treatment of ILD depends heavily on the underlying type. There is no single regimen that fits every patient. Decisions are usually made by a pulmonologist with experience in ILD, often as part of a multidisciplinary team. Major aims include:

• Treating any underlying cause (autoimmune disease, exposure, medication trigger)
• Reducing inflammation where it is driving damage
• Slowing fibrosis where scarring is the main process
• Supporting oxygen levels
• Improving exercise capacity and quality of life
• Preventing complications such as infections and exacerbations

Antifibrotic Medications

Two antifibrotic drugs, pirfenidone and nintedanib, are widely used in IPF and have been shown in clinical trials to slow the decline in lung function. Nintedanib is also approved in many countries for other progressive fibrosing ILDs and for scleroderma-associated ILD. ATS/ERS guidelines support their use in selected patients. These medications do not reverse scarring, but they can change the trajectory of the disease.

Both can cause side effects — pirfenidone often causes nausea, rash, and sun sensitivity; nintedanib often causes diarrhoea and can affect liver function. Your specialist will monitor blood tests and may adjust dosing.

Anti-Inflammatory and Immunosuppressive Therapy

For ILDs driven by inflammation rather than fibrosis — including many connective tissue disease-associated ILDs, hypersensitivity pneumonitis, sarcoidosis, and organising pneumonia — corticosteroids such as prednisolone are often used. Steroid-sparing immunosuppressants such as mycophenolate, azathioprine, or rituximab may be added or substituted to limit long-term steroid side effects.

Importantly, in IPF specifically, current guidelines advise against long-term immunosuppression because earlier studies showed it can be harmful. This is why getting the specific diagnosis right matters so much.

Treating the Underlying Cause

If your ILD is linked to an autoimmune disease, treating that disease — with a rheumatologist’s input — is central. If hypersensitivity pneumonitis is identified, finding and removing the trigger (such as a pet bird or mouldy environment) is often the most important single step. If a medication is the cause, your doctor will weigh stopping or switching it.

Oxygen Therapy

When blood oxygen drops below certain levels at rest or during activity, supplemental oxygen is recommended. Oxygen can:

• Reduce breathlessness during activity
• Improve exercise tolerance
• Reduce strain on the heart
• Improve sleep quality where night-time oxygen drops occur

Oxygen may be needed only during exercise or sleep at first, and around the clock later if the disease advances. Portable concentrators allow continued mobility, including travel after medical clearance.

Pulmonary Rehabilitation

Pulmonary rehabilitation is a structured programme that combines supervised exercise, education, breathing techniques, and emotional support. It is one of the most consistently helpful interventions for people with chronic lung disease. Studies show it can improve walking distance, reduce breathlessness, and improve quality of life in ILD. Many pulmonologists consider it a core part of ILD care.

Vaccinations and Infection Prevention

People with ILD are more vulnerable to chest infections. Vaccinations recommended for most ILD patients include annual influenza, pneumococcal vaccines, COVID-19, and where appropriate, RSV and pertussis. Discuss the right schedule with your doctor.

Managing Reflux and Other Coexisting Conditions

Gastro-oesophageal reflux is common in ILD, particularly in IPF, and may contribute to ongoing lung injury. Treatment with acid-suppressing medication is often considered. Other conditions such as obstructive sleep apnoea, pulmonary hypertension (high pressure in the lung arteries), and heart disease are checked for and treated.

Lung Transplantation

For carefully selected patients with advanced ILD whose disease continues to progress despite treatment, lung transplantation can be life-extending. It involves significant lifelong commitment to immunosuppression and follow-up. Referral to a transplant centre is usually considered earlier rather than later in IPF and other fibrotic ILDs, because waiting times and donor availability vary.

Clinical Trials

Because ILD research is advancing quickly, your specialist may discuss participation in a clinical trial of a new antifibrotic or anti-inflammatory therapy. Trials are an important option for some patients, particularly those whose disease is progressing on standard treatment.

Lifestyle and Self-Management

Day-to-day choices can make a real difference in how you feel and how your lungs cope.

Stop Smoking

If you smoke, stopping is the single most important thing you can do for your lungs. Your specialist or family doctor can help you access support such as counselling and medications to assist with quitting.

Avoid Triggers

If a workplace dust, mould, bird, or chemical has been identified as a trigger, ongoing exposure can continue to drive lung damage even with treatment. Modifying your home or workplace, or changing roles where possible, may be necessary.

Stay Active Within Your Limits

Techniques such as pursed-lip breathing (breathing out slowly through pursed lips) and diaphragmatic breathing can ease breathlessness during activity and recovery. A pulmonary rehabilitation therapist can teach these.

Nutrition and Weight

Both being underweight and being overweight can worsen breathlessness in ILD. A balanced diet supports energy levels and immune function. Some people lose weight unintentionally and may benefit from a referral to a dietitian.

Sleep and Rest

Many people with ILD experience disturbed sleep, partly due to low oxygen at night or coexisting sleep apnoea. Sleep studies and overnight oxygen monitoring may be useful if you wake unrefreshed or your partner notices snoring or pauses in breathing.

Energy Conservation

Simple strategies — sitting to shower, prioritising important tasks earlier in the day, breaking jobs into smaller steps — can help you do more of what matters with less breathlessness.

Monitoring and Follow-Up

Because ILD can be unpredictable, regular monitoring is part of long-term care. Your specialist will usually arrange:

• Pulmonary function tests every three to six months at first, then less often if stable
• Oxygen checks, including walk tests, to detect drops with exertion
• HRCT scans when there is a change in symptoms or treatment
• Blood tests to monitor medication side effects and underlying autoimmune activity
• Assessment for pulmonary hypertension using echocardiogram if symptoms or oxygen levels suggest it

Keeping a simple symptom diary — noting breathlessness, cough, exercise tolerance, and weight — gives your team useful information between visits.

Complications

ILD can lead to several complications. Knowing about them helps you recognise problems early.

• Acute exacerbations — sudden worsening of breathlessness, often without a clear infection, that may require hospital care
• Chest infections — lungs already affected by ILD are more vulnerable to pneumonia
• Pulmonary hypertension — high pressure in the arteries supplying the lungs, which can worsen breathlessness and strain the heart
• Respiratory failure — oxygen levels too low to meet the body’s needs, sometimes requiring continuous oxygen or hospitalisation
• Heart problems — right-sided heart strain (cor pulmonale) over time
• Increased risk of lung cancer in some forms of fibrotic ILD
• Side effects of long-term medications — including bone thinning with steroids, infection risk with immunosuppressants, and liver or gastrointestinal effects with antifibrotics

Living with Interstitial Lung Disease

Living with a chronic lung condition affects more than your breathing. Many people describe a mix of frustration, anxiety, and grief alongside the physical symptoms. Acknowledging this is part of good care, not a sign of weakness.

Emotional Wellbeing

Anxiety about breathlessness and depression are common in ILD. Talking with a counsellor or psychologist, joining a support group of others living with ILD, or speaking openly with family can help. Some symptoms of anxiety — rapid breathing, chest tightness — can mimic or worsen breathlessness, and learning to recognise and manage them improves quality of life.

Family and Caregivers

ILD affects partners and family members too. Involving them in clinic visits, pulmonary rehabilitation education sessions, and decisions about home oxygen or future care helps everyone prepare.

Work and Daily Roles

Depending on the type of ILD and how far it has progressed, many people continue working with adjustments. For others, especially where the cause is occupational, a change of role may be necessary. Open conversations with your employer and pulmonologist can help shape practical adjustments.

Travel

Travel is often possible, including air travel, with planning. Aeroplane cabins have lower oxygen levels than ground level, so people who need oxygen at sea level often need more in flight. Your pulmonologist may recommend a hypoxic challenge test before flying and can advise on portable oxygen, airline notification, and pacing.

Advance Care Planning

For some forms of ILD, particularly progressive fibrotic types, it is helpful to have conversations — well before any crisis — about preferences for care if the disease advances. This includes wishes around hospitalisation, intensive care, and palliative support. Palliative care specialists work alongside lung specialists and focus on symptom relief and quality of life at any stage of illness, not only at the end of life.

Interstitial Lung Disease in Children

Children can develop interstitial lung disease, but the causes and patterns are largely different from those in adults. The collective term used is childhood interstitial lung disease (chILD). It includes genetic disorders of surfactant production (a substance that helps the lungs expand), developmental lung disorders, infections, immune disorders, and ILD related to systemic disease.

Signs in children may include rapid breathing, poor weight gain, recurrent chest infections, and low oxygen levels. Diagnosis often involves specialised paediatric pulmonology centres, genetic testing, and sometimes lung biopsy. Treatment may include corticosteroids, hydroxychloroquine, immunosuppressants, oxygen, nutritional support, and management of any underlying genetic or immune condition.

Because chILD is rare and very different from adult ILD, care is best provided by paediatric pulmonologists with experience in these conditions. If you are a parent reading this for a child, the information in the adult sections above is a general orientation only; specific decisions should be guided by a paediatric ILD team.

Preventing Progression and Complications

While not every form of ILD can be prevented from progressing, several steps can meaningfully reduce the risk of worsening or complications:

• Take prescribed antifibrotic, anti-inflammatory, or immunosuppressive medications as directed and attend monitoring blood tests
• Stop smoking and avoid secondhand smoke
• Remove or reduce exposure to identified triggers at home and work
• Keep vaccinations up to date
• Treat reflux, sleep apnoea, and heart conditions actively
• Attend pulmonary rehabilitation if available
• Recognise warning signs of exacerbation early
• Maintain regular follow-up even when feeling stable

When to Seek Urgent Care

Contact your specialist or seek urgent medical attention if you experience:

• Sudden or rapidly worsening shortness of breath
• A new or worsening cough with fever or coloured sputum
• Chest pain, especially if severe or with breathlessness
• A noticeable drop in your home oxygen readings
• Coughing up blood
• New confusion, drowsiness, or bluish lips or fingertips
• Swelling of the legs combined with worsening breathlessness

These can be signs of an acute exacerbation, chest infection, blood clot, or heart strain — all of which need prompt assessment.

Frequently Asked Questions

Is interstitial lung disease curable?

Most forms of ILD are not curable in the sense of being fully reversed. However, several forms can be controlled or stabilised for long periods, especially when caught early, when an underlying cause is identified and treated, and when antifibrotic or anti-inflammatory therapy is used appropriately. Lung transplantation is considered in selected advanced cases.

How quickly does ILD progress?

The pace varies enormously between types and between individuals. Some forms, such as cryptogenic organising pneumonia, can resolve substantially with treatment. Others, such as IPF, tend to progress despite treatment, although antifibrotic medications can slow this. Your pulmonologist can give a more personalised picture based on your specific diagnosis, lung function trends, and HRCT pattern.

Will I need oxygen forever?

Not everyone with ILD needs oxygen. Some need it only with exertion, some only at night, and some not at all. Whether oxygen becomes a long-term need depends on the type of ILD and how it progresses. Your specialist will reassess your oxygen requirement over time.

Is ILD genetic? Should my family be tested?

Most ILD is not inherited, but a small proportion runs in families — called familial pulmonary fibrosis. If two or more close blood relatives have pulmonary fibrosis or related conditions, your specialist may discuss genetic counselling and testing. Routine testing of all family members is generally not recommended.

Can I exercise with ILD?

Yes, and exercise is encouraged for most people with ILD. The right level depends on your lung function and oxygen levels. A pulmonary rehabilitation programme is the safest way to start, because exercise is supervised and oxygen is monitored. Even gentle, regular activity can help preserve function and reduce breathlessness.

Can ILD patients get vaccinated safely?

Yes. People with ILD are usually advised to receive routine adult vaccinations including annual influenza, pneumococcal, COVID-19, and others as recommended for their age and condition. If you are on immunosuppressants, certain live vaccines may be avoided — your specialist will guide you.

Who treats interstitial lung disease?

ILD is typically managed by a pulmonologist (a doctor specialising in lung diseases), ideally one with experience in interstitial lung disease and access to a multidisciplinary team including a chest radiologist, a rheumatologist where autoimmune disease is involved, and a thoracic surgeon for biopsies or transplant referrals. Look for centres that see ILD regularly and offer pulmonary rehabilitation.

Can I travel by air with ILD?

Many people with ILD can fly safely with planning. Because cabin oxygen levels are lower than at ground level, your specialist may arrange a hypoxic challenge test and recommend in-flight oxygen if needed. Airlines have specific procedures for arranging oxygen, and travel insurance disclosures are important.

Conclusion

Interstitial lung disease is not one illness but a family of conditions, and the path through it looks different for each person. Some forms can be calmed substantially. Some can be slowed. All benefit from early, accurate diagnosis, careful identification of the underlying cause, and a long-term partnership with a pulmonologist experienced in ILD.

Modern care brings together antifibrotic medications, treatments aimed at any underlying autoimmune or inflammatory disease, supplemental oxygen where needed, pulmonary rehabilitation, vigilant management of complications, and, for selected patients, lung transplantation. Alongside these medical steps, the choices you make day to day — about smoking, exposures, activity, vaccinations, and follow-up — have a real and continuing impact.

A diagnosis of ILD changes how you breathe, but with informed, structured care it does not have to define the shape of your life. The most useful next step is a clear conversation with a specialist who can confirm your exact type of ILD and map out the treatment and monitoring plan that fits your situation.